Local NewsOVAX Inc. raised $10 million to commercialize research from the lab of Colin Haile, a research associate professor of psychology at UH and the Texas Institute for Measurement, Evaluation and Statistics , and a founding member of the UH Drug Discovery Institute.The vaccine, named Fentanyl Armour, prevents the drug from reaching the brain, thus eliminating the drug’s “high.” When developing the vaccine, Haile and his team called it a “game changer” in the war on fentanyl.
‘We’ve made great progress’: UH scientists who created anti-fentanyl vaccine step closer to becoming FDA-approved “This breakthrough discovery could have major implications for the nation’s opioid epidemic by becoming a relapse prevention agent for people trying to quit using opioids,” Haile said.